Stem cells in hematological therapies: a literature review

Detalhes bibliográficos
Autor(a) principal: Moraes , Ashlley Souza de
Data de Publicação: 2022
Outros Autores: Souza, Caio Robert Rodrigues Martins de, Lima , Cleyton Bismark de Oliveira, Silva , Isadora Góes, Souza, Jenifer da Silva, Santos, José Alencar de Santana, Silva, Lais Rodrigues, Santos, Lucas Siqueira dos, Santana, Milenna Freitas, Maranhão , Milena Viana, Vale, Nathalia dos Santos, Lordêlo, Isana Carla Leal Souza
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/29073
Resumo: Objective: To describe the advances in science regarding the use of stem cells for the treatment of hematological pathologies. Methodology: This is a literature review, descriptive and exploratory. Searches were carried out on the following platforms: Scientific Library Online (SciELO), Virtual Health Library (BVS), The Lancet, BrazilianJournalOf Health Review. Therapy with hematopoietic stem cells (HSC) is pioneered by the hematopoietic stem cell transplantation method, where these cells are infused into the patient himself. There are currently four sources of HSC: Peripheral blood; Bone marrow; The umbilical cord; Haploidentical Donor. Results and Discussion: Hematopoietic stem cell transplantation (HSCT) has specificities according to its modality, with protocols and chemotherapy regimens pre-established according to the disease, in addition to care at different levels of complexity. HSCT is a complex and invasive treatment, an increasing number of variables must be controlled to improve the patient's quality of life. Thus, with the advancement of technology and the assistance of the multidisciplinary team, regarding the appearance of symptoms, the method becomes positive for the treatment of the patient. However, it must be performed in a unique way regarding the care and symptoms that may occur. Conclusion: Therefore, the theme highlights the treatment and its importance for the present day and the benefit and hope that the treatment can offer to the patient when it does not have a positive prognosis when the disease is at an advanced stage.
id UNIFEI_94970163c7aabc450357ae4565f7e465
oai_identifier_str oai:ojs.pkp.sfu.ca:article/29073
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Stem cells in hematological therapies: a literature reviewCélulas madre em terapias hematológicas: una revisión de la literaturaCélulas tronco em terapias hematológicas: uma revisão de literaturaStemcellsHematologyTransplantation.Células madreHematologíaTrasplante.Células troncoHematologiaTransplante.Objective: To describe the advances in science regarding the use of stem cells for the treatment of hematological pathologies. Methodology: This is a literature review, descriptive and exploratory. Searches were carried out on the following platforms: Scientific Library Online (SciELO), Virtual Health Library (BVS), The Lancet, BrazilianJournalOf Health Review. Therapy with hematopoietic stem cells (HSC) is pioneered by the hematopoietic stem cell transplantation method, where these cells are infused into the patient himself. There are currently four sources of HSC: Peripheral blood; Bone marrow; The umbilical cord; Haploidentical Donor. Results and Discussion: Hematopoietic stem cell transplantation (HSCT) has specificities according to its modality, with protocols and chemotherapy regimens pre-established according to the disease, in addition to care at different levels of complexity. HSCT is a complex and invasive treatment, an increasing number of variables must be controlled to improve the patient's quality of life. Thus, with the advancement of technology and the assistance of the multidisciplinary team, regarding the appearance of symptoms, the method becomes positive for the treatment of the patient. However, it must be performed in a unique way regarding the care and symptoms that may occur. Conclusion: Therefore, the theme highlights the treatment and its importance for the present day and the benefit and hope that the treatment can offer to the patient when it does not have a positive prognosis when the disease is at an advanced stage.Objetivo: Describir los avances de la ciencia en cuanto al uso de células madre para el tratamiento de patologías hematológicas. Metodología: Se trata de una revisión bibliográfica, descriptiva y exploratoria. Las búsquedas se realizaron en las siguientes plataformas: Scientific Library Online (SciELO), Virtual Health Library (BVS), The Lancet, BrazilianJournalOf Health Review. La terapia con células madre hematopoyéticas (HSC) es iniciada por el método de trasplante de células madre hematopoyéticas, donde estas células se infunden en el propio paciente. Actualmente existen cuatro fuentes de HSC: Sangre periférica; Médula ósea; Cordón umbilical; Donante haploidéntico. Resultados y Discusión: El trasplante de progenitores hematopoyéticos (TPH) tiene especificidades según su modalidad, con protocolos y esquemas de quimioterapia preestablecidos según la enfermedad, además de cuidados en diferentes niveles de complejidad. El TCMH es un tratamiento complejo e invasivo, se debe controlar un número creciente de variables para mejorar la calidad de vida del paciente. Así, con el avance de la tecnología y la asistencia del equipo multidisciplinario, en cuanto a la aparición de síntomas, el método se torna positivo para el tratamiento del paciente. Sin embargo, debe realizarse de forma única en cuanto a los cuidados y síntomas que se puedan presentar. Conclusión: Por lo tanto, el tema destaca el tratamiento y su importancia para la actualidad y el beneficio y la esperanza que el tratamiento puede ofrecer al paciente cuando no tiene un pronóstico positivo cuando la enfermedad se encuentra en una etapa avanzada.Objetivo: Descrever os avanços da ciência no que diz respeito a utilização de células tronco para o tratamento de patologias hematológicas. Metodologia: Trata-se de uma revisão de literatura, de natureza descritiva e exploratória. Foram realizadas buscas nas seguintes plataformas: Scientific Library Online (SciELO), Biblioteca Virtual em Saúde (BVS), The Lancet, BrazilianJournalOf Health Review. A terapia com células-tronco hematopoiéticas (CTH) ocorre pioneiramente pelo método de transplante de células tronco hematopoiéticas, onde ocorre a infusão dessas células no próprio paciente. Atualmente há quatro fontes de CTH: Sangue periférico; Médula óssea; Cordão umbilical; Doador Haploidêntico. Resultados e Discussão: O Transplante de células tronco hematopoéticas (TCTH) possui especificidades de acordo com sua modalidade, com protocolos e esquemas quimioterápicos preestabelecidos conforme a doença, além de cuidados em diferentes níveis de complexidade. O TCTH é um tratamento complexo e invasivo, um quantitativo crescente de variáveis deve ser controlados para melhoria e qualidade de vida do paciente. Assim,com o avanço da tecnologia e a assistência da equipe multiprofissional, quanto ao aparecimento dos sintomas, o método torna-se positivo ao tratamento do paciente. Contudo, deve-se ser realizado de forma singular quanto aos cuidados e sintomas que venham ocorrer. Conclusão: Portanto, a temática evidencia o tratamento e sua importância para os dias atuais e transparece nos dados o benefício e a esperança que o tratamento pode oferecer ao paciente quando o mesmo não possui um prognóstico positivo quando a doença está em um estágio avançado.Research, Society and Development2022-05-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2907310.33448/rsd-v11i7.29073Research, Society and Development; Vol. 11 No. 7; e32511729073Research, Society and Development; Vol. 11 Núm. 7; e32511729073Research, Society and Development; v. 11 n. 7; e325117290732525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/29073/25911Copyright (c) 2022 Ashlley Souza de Moraes ; Caio Robert Rodrigues Martins de Souza; Cleyton Bismark de Oliveira Lima ; Isadora Góes Silva ; Jenifer da Silva Souza; José Alencar de Santana Santos; Lais Rodrigues Silva; Lucas Siqueira dos Santos; Milenna Freitas Santana; Milena Viana Maranhão ; Nathalia dos Santos Vale; Isana Carla Leal Souza Lordêlohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMoraes , Ashlley Souza de Souza, Caio Robert Rodrigues Martins de Lima , Cleyton Bismark de Oliveira Silva , Isadora Góes Souza, Jenifer da Silva Santos, José Alencar de Santana Silva, Lais Rodrigues Santos, Lucas Siqueira dos Santana, Milenna Freitas Maranhão , Milena Viana Vale, Nathalia dos Santos Lordêlo, Isana Carla Leal Souza 2022-06-06T15:12:05Zoai:ojs.pkp.sfu.ca:article/29073Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:46:15.110817Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Stem cells in hematological therapies: a literature review
Células madre em terapias hematológicas: una revisión de la literatura
Células tronco em terapias hematológicas: uma revisão de literatura
title Stem cells in hematological therapies: a literature review
spellingShingle Stem cells in hematological therapies: a literature review
Moraes , Ashlley Souza de
Stemcells
Hematology
Transplantation.
Células madre
Hematología
Trasplante.
Células tronco
Hematologia
Transplante.
title_short Stem cells in hematological therapies: a literature review
title_full Stem cells in hematological therapies: a literature review
title_fullStr Stem cells in hematological therapies: a literature review
title_full_unstemmed Stem cells in hematological therapies: a literature review
title_sort Stem cells in hematological therapies: a literature review
author Moraes , Ashlley Souza de
author_facet Moraes , Ashlley Souza de
Souza, Caio Robert Rodrigues Martins de
Lima , Cleyton Bismark de Oliveira
Silva , Isadora Góes
Souza, Jenifer da Silva
Santos, José Alencar de Santana
Silva, Lais Rodrigues
Santos, Lucas Siqueira dos
Santana, Milenna Freitas
Maranhão , Milena Viana
Vale, Nathalia dos Santos
Lordêlo, Isana Carla Leal Souza
author_role author
author2 Souza, Caio Robert Rodrigues Martins de
Lima , Cleyton Bismark de Oliveira
Silva , Isadora Góes
Souza, Jenifer da Silva
Santos, José Alencar de Santana
Silva, Lais Rodrigues
Santos, Lucas Siqueira dos
Santana, Milenna Freitas
Maranhão , Milena Viana
Vale, Nathalia dos Santos
Lordêlo, Isana Carla Leal Souza
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Moraes , Ashlley Souza de
Souza, Caio Robert Rodrigues Martins de
Lima , Cleyton Bismark de Oliveira
Silva , Isadora Góes
Souza, Jenifer da Silva
Santos, José Alencar de Santana
Silva, Lais Rodrigues
Santos, Lucas Siqueira dos
Santana, Milenna Freitas
Maranhão , Milena Viana
Vale, Nathalia dos Santos
Lordêlo, Isana Carla Leal Souza
dc.subject.por.fl_str_mv Stemcells
Hematology
Transplantation.
Células madre
Hematología
Trasplante.
Células tronco
Hematologia
Transplante.
topic Stemcells
Hematology
Transplantation.
Células madre
Hematología
Trasplante.
Células tronco
Hematologia
Transplante.
description Objective: To describe the advances in science regarding the use of stem cells for the treatment of hematological pathologies. Methodology: This is a literature review, descriptive and exploratory. Searches were carried out on the following platforms: Scientific Library Online (SciELO), Virtual Health Library (BVS), The Lancet, BrazilianJournalOf Health Review. Therapy with hematopoietic stem cells (HSC) is pioneered by the hematopoietic stem cell transplantation method, where these cells are infused into the patient himself. There are currently four sources of HSC: Peripheral blood; Bone marrow; The umbilical cord; Haploidentical Donor. Results and Discussion: Hematopoietic stem cell transplantation (HSCT) has specificities according to its modality, with protocols and chemotherapy regimens pre-established according to the disease, in addition to care at different levels of complexity. HSCT is a complex and invasive treatment, an increasing number of variables must be controlled to improve the patient's quality of life. Thus, with the advancement of technology and the assistance of the multidisciplinary team, regarding the appearance of symptoms, the method becomes positive for the treatment of the patient. However, it must be performed in a unique way regarding the care and symptoms that may occur. Conclusion: Therefore, the theme highlights the treatment and its importance for the present day and the benefit and hope that the treatment can offer to the patient when it does not have a positive prognosis when the disease is at an advanced stage.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-26
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/29073
10.33448/rsd-v11i7.29073
url https://rsdjournal.org/index.php/rsd/article/view/29073
identifier_str_mv 10.33448/rsd-v11i7.29073
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/29073/25911
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 7; e32511729073
Research, Society and Development; Vol. 11 Núm. 7; e32511729073
Research, Society and Development; v. 11 n. 7; e32511729073
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052711318847488